Poddar, Subhajit; Farzan, Michael; and Diamond, Michael S., ,"The interferon-stimulated gene IFITM3 restricts West Nile virus infection and pathogenesis." The Journal of Virology.90,18. 8212-8225. (2016). experiments demonstrated that Ifitm3 functioned in both radioresistant and radiosensitive cells, 36 as higher levels of WNV were observed in the brain only when Ifitm3 was absent from both 37 compartments. Our analyses suggest that Ifitm3 restricts WNV pathogenesis likely through 38 multiple mechanisms including the direct control of infection in subsets of cells.
Ifitm3
-/-mice are more susceptible to influenza A virus (IAV) infection (3, 43). These studies 84 described increased IAV titers in the lung, increased pathology, and decreased CD4 + T cells, 85
CD8
+ T cells, and NK cells in Ifitm3 -/-compared to WT mice. One of these studies described a 86 human polymorphism in IFITM3, (SNP-rs12252-C) that results in an altered splice acceptor site, 87 immunological analysis revealed that Ifitm3 -/-mice were more vulnerable to WNV infection with 105 greater lethality, higher viral burden, and altered immune induction. Our study demonstrates a
MATERIALS AND METHODS 110
Ethics statement. This study was carried out in strict accordance with the 111 recommendations in the Guide for the Care and Use of Laboratory Animals of the National 112
Institutes of Health. The protocols were approved by the Institutional Animal Care and Use 113
Committee at the Washington University School of Medicine (Assurance Number: A3381-01). 114
Dissections and footpad injections were performed under anesthesia that was induced and 115 maintained with ketamine hydrochloride and xylazine, and all efforts were made to minimize 116
suffering. 117
Virus propagation. The WNV strain New York 1999 (53, 54) was passaged in Vero 118 cells to generate a mammalian cell derived stock. The WNV strain from Madagascar (DakAnMg 119
798, WNV-MAD) was isolated in 1978 and also passaged in Vero cells (55). Titration of viral 120
stocks was performed using a focus-forming assay as described previously (56). 121
Mouse experiments and tissue preparation Wild-type (WT) C57BL/6 (000664) or 122 B6.SJL (002014) mice were purchased from Jackson Laboratory.
Ifitm3
-/-mice were generated 123 previously (57), backcrossed using speed congenics onto a C57BL/6J background, and bred in 124 a pathogen free animal facility at the Washington University School of Medicine. Eight to ten 125 week-old age and sex-matched mice were used. Mice were infected via a subcutaneous (10 2 126 FFU in 50 μl) or intracranial (10 1 FFU in 10 μl) route with virus diluted in PBS. For survival 127 studies, infected mice were monitored for 21 days. For viral burden studies, at specified time 128 points after infection, serum was collected and animals were perfused with 20 ml of PBS. 129 reduction neutralization assay were performed on Vero cells after mixing serial dilutions of 136 serum with a fixed amount (10 2 FFU) of WNV (56). 137
Analysis of cellular immune responses. Splenocytes were harvested from WT or 138
-/-mice on day 7 or 8 after WNV infection. Lymphocyte populations were stained using 139
anti-CD3-V500 (560711; BD Bioscience), anti-CD8α-or anti-CD8β-Percp Cy5.5 (100734; 140 Biolegend), anti-CD19-AlexaFluor700 (115528; Biolegend), anti-CD4-BV421 (100437; 141 Biolegend), anti-granzyme B (GRB04; Invitrogen), and tetramers specific for a D b -restricted 142 immunodominant peptide in NS4B (62). Brains were harvested from WT or Ifitm3 -/-mice on day 143 8 after WNV infection. CNS leukocytes were isolated by Percoll gradient centrifugation as 144 described previously (62, 63) and stained with the antibodies and tetramer described above in 145 addition to anti-CD11b-PE-Cy7 (101216; Biolegend) and anti-CD45-BV605 (103139; 146 Biolegend). Cells were analyzed on a BD LSRII flow cytometer and data were processed using 147
FlowJo software. 148
To examine intracellular cytokine production by CD4 + and CD8 + T cells, anti-CD3 or 149 antigen-specific peptide restimulation was performed (62). In brief, splenocytes were isolated 150 and stimulated with anti-CD3 (100207; Biolegend), the immunodominant NS4B peptide, or no 151 stimulation. Cells were incubated for 6 h at 37 o C in the presence of brefeldin A and then fixed 152 and permeablized using the FoxP3/Transcription Factor Staining Buffer set (00-5523-00; 153 eBioscience). Subsequently, cells were stained with anti-CD4-BV421 (100437; Biolegend), anti-154
CD8β-PerCP-Cy5.5 (126609; Biolegend), anti-CD19-AlexaFluro700 (115528; Biolegend), anti-155 IFN-γ-APC (51-73-1182; eBioscience), and anti-TNF-α-PE (506306l Biolegend) antibodies and 156
analyzed. 157
Primary cell isolation and infection. Primary macrophages (Mφ), dendritic cells (DCs), 158 and mouse embryonic fibroblasts (MEFs) were generated from WT and Ifitm3 -/-mice as 159 described (64). For single-step and multi-step growth curves, cells were infected at a multiplicity 160 9 of infection (MOI) of 5 and 0.01, respectively. In some experiments, cells were pretreated with 161 IFN-β (12400-1; PBL Assay Science) for 16 h before infection. Viral supernatants were 162 harvested and titered using a focus-forming assay. 163
Transformation of MEFs. MEFs were transfected with the plasmid SV2, which encodes 164
for the large T antigen of SV40 polyoma virus (65). Cells were passaged ~10 times and used for 165 subsequent experiments. were more vulnerable to WNV infection than WT mice, as a greater percentage (90% versus 225 40% lethality, P < 0.001) succumbed to disease (Fig 1A) . The mean time to death of Ifitm3 Relatively small, yet statistically significant differences in viral burden were observed in 236 some peripheral organs. For example, viremia was equivalent at day 2 after WNV infection but 237 higher at days 4 and 6 in Ifitm3 -/-compared to WT mice (Fig 1B, P < 0.01). Increased viral titers 238 also were detected in the draining lymph node (DLN) days 6 and 8 after infection (Fig 1C, in the cerebral cortex, white matter, brain stem, cerebellum, and spinal cord was measured on 256 days 3 and 5 after infection. Notably, no difference in viral burden was detected in CNS tissues 257 on day 3 or day 5 after infection (Fig 2A-F -/-mice after WNV infection (Fig 3A-F, and M) . To assess whether antigen-275 specific CD8
+ T cells showed qualitative defects in the absence of Ifitm3, splenocytes were from 276 WNV-infected mice were stimulated ex vivo with an immunodominant WNV NS4B peptide and 277 tested for cytokine production. However, equivalent percentages, numbers, and geometric 278 mean fluorescence intensity of IFN-γ and TNF-α producing CD8 + T cells were detected in WT 279
and Ifitm3 -/-mice (Fig 3G-L and N Also, after ex vivo restimulation with the NS4B peptide, equivalent percentages and numbers of 288 IFN-γ and TNF-α secreting CD8 + T cells were measured from the brains of WT and Ifitm3 -/-mice 289 (Fig 4M-R, and 4T , P > 0.05). Thus, while a small decrease in CD8 + T cell response in the 290 periphery of WNV-infected Ifitm3 -/-mice was observed, it did not appear to impact clearance of 291 virus in the spleen (see Fig 1C) or accumulation of antigen-specific immune cells in the brain. -/-mice at 296 day 7 after infection (Fig 5A and B) 
Ifitm3
-/-mice. (Fig 6A) , pretreatment of ifitm3 -/-Mφ with low 312 doses of IFN-β to stimulate ISG production did produce marginally higher levels virus (Fig 6B-313   C) . In comparison, unstimulated or IFN-β-treated Ifitm3 -/-DC did not support statistically 314 increased WNV infection (Fig 6D-F) . However, multi-step growth analysis demonstrated 315 increased WNV yield in the supernatants of Ifitm3 -/-compared to WT MEFs (Fig 6G, P < 0. 
05) 316
and this difference was amplified under conditions of IFN-β pre-treatment (Fig 6H, P < 
ifitm3
-/-MEFs (Fig 6I, P>0 .05) although pretreatment with IFN-β did show an effect (Fig 6J, P  319 <0.05). Thus, Ifitm3 restricts WNV infection in some cell types although its expression must be 320 induced to observe this phenotype. 321
To confirm that the increased permissiveness of Ifitm3 -/-MEF for WNV was due to the 322 loss of Ifitm3, we trans-complemented cells with a c-Myc tagged form of Ifitm3 (c-Myc-Ifitm3) 323
and compared this to a control c-Myc tagged form of Firefly luciferase (c-Myc-FLUC) (Fig 6K-324   M) . Lentiviral-mediated expression of c-Myc tagged Ifitm3 first was validated by Western 325 blotting (Fig 6K) . in vivo, we generated reciprocal bone marrow chimera using congenic CD45.1 + (WT) and 337
CD45.2
+ (Ifitm3 -/-) donor and recipient mice, and viral burden was measured at 7 days after 338 infection (Fig 7A-B) . Due to the process of irradiation and reconstitution, the chimeric mice 339 necessarily were infected at an older age, 16 weeks, compared to the other studies (see Fig 1) . 340
Bone marrow chimeras with Ifitm3
-/-or WT radio-resistant non-hematopoietic cells (WTIfitm3
-/-WT) had equivalent levels of virus in serum, draining lymph node and spinal cord 342 (Fig 7C-F 
Ifitm3
-/-) sustained higher titers in the brain (Fig 7E, P < 0 .05), as seen with the direct 344 gene deletions (see Fig 1) . Analysis of the adaptive immune response revealed minor 345 differences in the chimeric mice. The percentage of CD19 + B cells was higher in Ifitm3
346
/-mice (Fig 7G) , but no difference in the absolute number of CD19 + B cells was observed (Fig  347   7H) . CD4 + T cell numbers and percentages in the spleen also were similar (Fig 7I-J) (Fig 7K) , 349 but this did not affect the total number of CD8 + T cells or the number or percentage of NS4B 350 tetramer + CD8 + T cells (Fig 7L-N) . Thus, Ifitm3 expression in both radioresistant and 351 radiosensitive cell compartments contributes to the control of WNV infection, and only when 352 there is a lack of Ifitm3 in both compartments is the phenotype of enhanced infection in the CNS 353 independent experiments were performed. Asterisks indicate statistically significant differences 702 by the Mann-Whitney test (* P < 0.05, ** P < 0.01, *** P < 0.001). 703 per independent experiment, and 4 independent experiments were performed. Statistical 723 significance was determined by the Mann-Whitney test (* P < 0.05, ** P < 0.01). 724 antibody titers (C, D) were determined using an ELISA against purified WNV E protein. Serum 739 neutralization activity (E) was evaluated using an focus reduction neutralization test, and data 740 was fitted by regression analysis to obtain EC50 values. 2-5 mice were used per independent 741 experiment, and 4 independent experiments were performed. Statistical significance was 742 determined by the Mann-Whitney test (* P < 0.05). 
